Evidence map›Paper›PMID 31629468›Full record

ArticleBiochemical and biophysical research communications2019

Corrigendum to "The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor" [BBRC 511/4 (2019) 794-799].

Wen Cui, Shanshan Cui, Cheng Chen, Xia Chen, Zefang Wang, Haitao Yang, Lei Zhang

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Biochemical and biophysical research communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Wen CuiSchool of Life Sciences, Tianjin University, Tianjin International Joint Academy of Biotechnology and Medicine, State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, China.
Shanshan CuiSchool of Life Sciences, Tianjin University, Tianjin International Joint Academy of Biotechnology and Medicine, State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, China.
Cheng ChenSchool of Life Sciences, Tianjin University, Tianjin International Joint Academy of Biotechnology and Medicine, State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, China.
Xia ChenSchool of Life Sciences, Tianjin University, Tianjin International Joint Academy of Biotechnology and Medicine, State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, China.
Zefang WangSchool of Life Sciences, Tianjin University, Tianjin International Joint Academy of Biotechnology and Medicine, State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, China. Electronic address: zefangwang@tju.edu.cn.
Haitao YangSchool of Life Sciences, Tianjin University, Tianjin International Joint Academy of Biotechnology and Medicine, State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, China.
Lei ZhangSchool of Life Sciences, Tianjin University, Tianjin International Joint Academy of Biotechnology and Medicine, State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, China. Electronic address: zhanglei@tju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31629468
PMCPMC8445347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.